Jaguar Health Inc (NASDAQ:JAGX) was down 0.3% on Thursday . The stock traded as low as $0.17 and last traded at $0.17. Approximately 22,625 shares changed hands during mid-day trading, a decline of 100% from the average daily volume of 5,434,314 shares. The stock had previously closed at $0.17.
Several analysts recently commented on JAGX shares. ValuEngine downgraded Jaguar Health from a “buy” rating to a “hold” rating in a research note on Thursday, January 24th. HC Wainwright reaffirmed a “buy” rating on shares of Jaguar Health in a research note on Monday, April 15th.
TRADEMARK VIOLATION WARNING: This report was originally published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://dakotafinancialnews.com/2019/05/16/jaguar-health-jagx-stock-price-down-0-3.html.
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Featured Story: How much can an individual set aside as a catch-up contribution?
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.